Flash 7 is required to view this content. Download Flash 7.
Advancing Life Science Together ®
Al igual que los científicos e ingenieros son pioneros en nuevas curas para los problemas médicos más desafiantes de la humanidad, usted confía en Millipore como un socío confiable que durante más de 50 años le ha apoyado con un continuum de avanzadas herramientas, tecnologías y soluciones de aplicaciones para asegurar el éxito en su investigación, desarrollo y producción.

Mercados especiales
Diagnóstico y OEM, Vacunas, Bebidas, Agua potable y residual, Farmacia hospitalaria, Microelectrónica.
Sala multimedia

Millipore Reports Third Quarter 2009 Financial Results
Millipore reported financial results for its third quarter ended October 3, 2009. Revenues for the third quarter grew 4 percent from the previous year, totaling $412 million. Excluding a 3 percent unfavorable impact from changes in foreign currency, Millipore generated organic revenue growth of 7 percent. On a divisional basis, excluding changes in foreign currency, Millipore’s Bioprocess Division generated organic revenue growth of 8 percent, while the Company’s Bioscience Division generated organic revenue growth of 4 percent from the previous year.........

Millipore Corporation named Corporate Citizen of the Year
Corporate commitment to reduce global carbon footprint through clean energy is lauded

Millipore and Roka Bioscience to Develop Real-Time Molecular Tests for Biopharmaceutical Applications
Millipore announced that it will collaborate with Roka Bioscience, Inc. to develop molecular assays and portable instruments...









